to Content
Header Image

04: Biomedical and pharmaceutical engineering – key technologies of the 21st century

-
Hauptschule
Breakout /
in englischer Sprache

The challenges in biomedical technology as well as in the development and production of modern therapeutics have risen drastically. An important indicator of this trend is the significant reduction in the approval of new medicines since 1995.
This working group will deal with modern methods to counteract this development, e.g. by using modern “high-throughput methods” like “lab-on-a-chip”, nanotechnology and modern quality and risk management in combination with predictive modelling approaches. Computational medicine’s aim, for example, is to better analyze age-related diseases like atherosclerosis or osteoporosis. This approach to digitalize and personalize data will lead to better health care.

Consultant; retired Head, Technology Liaison, Global Quality Operations, Novartis Pharma AG, Dornach
Professor of Engineering Science; Director, Auckland Bioengineering Institute, The University of Auckland
Direktor, Institut für Biomechanik, Eidgenössische Technische Hochschule Zürich
James M. and Marsha McCormick Chair of Biomedical Engineering; Samuel B. Eckert Professor of Chemical Engineering, School of Chemical and Biomolecular Engineering, Cornell University, Ithaca
Full Professor and Chair of Biomechanics, Graz University of Technology; Adjunct Full Professor and Chair of Biomechanics, Department of Solid Mechanics, School of Engineering Sciences, Royal Institute of Technology (KTH), Stockholm; Visiting Professor, Department of Mathematics, University of Glasgow, Graz Chair
Head, Institute of Process- and Particle Engineering, Graz University of Technology; Scientific Director, Research Center Pharmaceutical Engineering GmbH, Graz Chair
Ph.D. Researcher, Institute of Process and Particle Engineering, Graz University of Technology Coordination

Dr. Fritz ERNI

Consultant; retired Head, Technology Liaison, Global Quality Operations, Novartis Pharma AG, Dornach

1969 Ph.D. from the Swiss Federal Institute of Technology (Dr. sc.nat. ETH) in Zurich
 Started his career in Japan in research at Hitachi Ltd.
1974-1986 Several positions in the analytical research and development of new drug substances and products at Sandoz in Basel
1986-1995 Head of Analytical Research and Development at Sandoz in Basel
1995-2000 Several management positions in Quality Assurance/Control at Sandoz and after the merger within Novartis
2000-2002 Director of Novartis Pharmanalytica SA in Locarno, Switzerland
2002-2009 Head of Technical Liaison, Global Quality Operations of Novartis in Basel (responsible for the establishing of Novartis Global activities on Process Analytical Technologies (PAT) and Quality by Design)
 Since 2009 Consultant (retired from Novartis after 35 years in the pharmaceutical Industry)

Ph.D. Peter J. HUNTER

Professor of Engineering Science; Director, Auckland Bioengineering Institute, The University of Auckland

1971 B.E. in Engineering Science (1st Class Hons) at Auckland University, NZ
1971-1972 Master s research in the Dept. of Theoretical & Applied Mechanics at Auckland University
1973-1975 Postgraduate research for D.Phil. in Physiology at Oxford University
1975-1977 Research Fellow and tutor at St. Catherine's College, Oxford University
Research Fellow at Rutherford Laboratory, UK
1977-1978 Engineering Lecturer at Keble College, Oxford
since 1979 Lecturer to Professor in Engineering Science at Auckland University
1998-1999 Associate Dean of Research in the School of Engineering
1999-2000 James Cook Fellow of the Royal Society of New Zealand
2001 Distinguished Professor, University of Auckland
since 2001 Director of Bioengineering Institute at Auckland University
since 2003 Director, Computational Physiology, University of Oxford

Dr. Ralph MÜLLER

Direktor, Institut für Biomechanik, Eidgenössische Technische Hochschule Zürich

1994 Promotion in Elektrotechnik, Eidgenössische Technische Hochschule Zürich
 Anschließend arbeitete er als Mikrotomographie Projektmanager für die BIOMED1 Concerted Action der Europäischen Union.
1996 Wechsel an die Harvard Medical School in Boston, wo er als tenure-tracked Assistant Professor of Orthopedic Surgery und als stellvertretender Direktor des Orthopedic Biomechanics Laboratory tätig war.
2000-2006 SNF Professor für Bioingenieurwissenschaften am Institut für Biomedizinische Technik der Universität und ETH Zürich
seit 2006 Professor für Biomechanik am Departement für Maschinenbau und Verfahrenstechnik und der Direktor des Instituts für Biomechanik an der ETH Zürich

Ph.D. Michael L. SHULER

James M. and Marsha McCormick Chair of Biomedical Engineering; Samuel B. Eckert Professor of Chemical Engineering, School of Chemical and Biomolecular Engineering, Cornell University, Ithaca

1969 B.Sc., Chemical Engineering, University of Notre Dame (Notre Dame, IN)
1973 Ph.D., Chemical Engineering, University of Minnesota (Minneapolis, MN)
1974-1979 Assistant Professor of Chemical Engineering, Cornell University
1979-1983 Associate Professor of Chemical Engineering, Cornell University
1980-1981 Visiting Scholar, Department of Chemical Engineering, University of Washington, Seattle
1984-1991 Professor of Chemical Engineering, Cornell University
1985-1988 Founding Editor, Biotechnology Progress (Board since 1988)
1986-2006 Editorial Board, AIChE (American Institute of Chemical Engineers) Journal
1988-1989 Visiting Prof., Dept. of Chemical Engineering, University of Wisconsin, Madison
since 1990 Editorial Board, Biotechnology and Bioengineering
1991-2001 Board of Directors, Phyton
since 1992 Samuel B. Eckert Professor of Chemical Engineering, Cornell University
since 1993 Director, Bioengineering Program
since 1994 Editorial Board, Enzyme and Microbial Technology
1995 Guest Professor, Institute for Biotechnology, ETH Zurich, Switzerland
1996-2008 Editorial Board, Cambridge University Press
1998-2002 Director, Chemical and Biomolecular Engineering
2001-2003 Board of Directors, American Institute of Chemical Engineers
2002-2004 Director, Biomedical Engineering Program
since 2004 James and Marsha McCormick Chair of Biomedical Engineering
  Scientific Advisory Board, HuRel
2005-2008 Scientific Advisory Board, Institute of Chemical and Engineering Sciences, Singapore

Dipl.-Ing. Dr. techn. Gerhard A. HOLZAPFEL

Full Professor and Chair of Biomechanics, Graz University of Technology; Adjunct Full Professor and Chair of Biomechanics, Department of Solid Mechanics, School of Engineering Sciences, Royal Institute of Technology (KTH), Stockholm; Visiting Professor, Department of Mathematics, University of Glasgow, Graz

1985 MSc. Civil Engineering (with distinction), Graz University of Technology (TU Graz), Austria
1986-1987 National Service at Red Cross
1987-1997 Assistant and Docent at the Institute of Strength of Materials, TU Graz
1990 PhD in Mechanical Engineering (with distinction), TU Graz
1991 Visiting Scholar at University of Shenyang, P.R. China
1993-1995 Post-Doctoral Fellow at the Division of Applied Mechanics, Department of Mechanical Engineering, Stanford University; with late Prof. JC Simo
1996 Habilitation in "Mechanics" Vienna University of Technology
1998-2004 Associate Professor and Head of the Research Group "Computational Biomechanics", Institute of Structural Analysis, TU Graz
2003 Visiting Professor, Universidad Politécnica de Cataluña, Barcelona, Spain
Offer of a Chair (C4) in Continuum Mechanics, University of Kassel, Germany (not accepted)
2004-2007 Full Professor and Chair of Biomechanics, Royal Institute of Technology (KTH), Stockholm, Sweden
2007 Visiting Professor, University of Zaragoza, Spain
since 2007 Full Professor and Chair of Biomechanics, Graz University of Technology; Adjunct Full Professor and Chair of Biomechanics, Department of Solid Mechanics, School of Engineering Sciences, Royal Institute of Technology (KTH), Stockholm
since 2009 Visiting Professor, Department of Mathematics, University of Glasgow, Scotland

DI Dr. techn. Johannes KHINAST

Head, Institute of Process- and Particle Engineering, Graz University of Technology; Scientific Director, Research Center Pharmaceutical Engineering GmbH, Graz

1991 DI in Chemical Engineering (highest distinction), Graz University of Technology
1995 Ph.D. in Chemical Engineering (highest distinction), Graz University of Technology
1996-1998 Post Doc in Chemical Engineering, University of Houston, Houston (TX)
1998-2003 Assistant Professor, Rutgers University, Piscataway (NJ)
since 2003 Tenured Professor, Rutgers University, Piscataway (NJ)
2003-2006 Director of the Rutgers Catalyst Consortium, Rutgers University, Piscataway (NJ)
since 2005 Professor of Pharmaceutical and Process Engineering
2005-2008 Marie Curie Chair of the European Union
since 2006 Head of the Institute for Process Engineering, Graz University of Technology
since 2008 Scientific Director of the Research Center for Pharmaceutical Engineering GmbH

Technology Forum

show timetable
Genre : all

27.08.2009

08:00 - 10:30Technology brunch of the Tiroler ZukunftsstiftungSocial
11:00 - 11:10Opening by the European Forum AlpbachPlenary
11:10 - 12:00Welcome statementsPlenary
12:00 - 14:00Pathways out of the crisis – new perspectives through research and innovation?Plenary
14:30 - 16:00The future of stem cell researchPlenary
18:00 - 19:30A look at the past – the secrets of our originPlenary
19:30 - 21:30Evening reception hosted by Forschung Austria in cooperation with GFF and BMVITSocial

28.08.2009

07:00 - 13:30Working Group 01: Can we trust in feed and food?Breakout
07:00 - 13:30Working Group 02: An international comparison of research, technology and innovation-policy (RTI) strategiesBreakout
07:00 - 13:30Working Group 03: “Sowing and harvesting” in bio(techno)logical research: From the atomic structure of proteins to the discovery of new drugs and their clinical applicationBreakout
07:00 - 13:30Working Group 04: Biomedical and pharmaceutical engineering – key technologies of the 21st centuryBreakout
07:00 - 13:30Working Group 05: Infratech – a chance in crisisBreakout
07:00 - 13:30Working Group 06: Creativity – fuel for the knowledge society?Breakout
07:00 - 13:30Working Group 07: Creative industries vs. old economy: where is the economy headed?Breakout
07:00 - 13:30Working Group 08: Universities: responsibility for the futureBreakout
07:00 - 13:30Working Group 09: Trust in the future – investment in researchBreakout
07:00 - 13:30Working Group 10: Digital Government – citizens and administration in a conflict areaBreakout
07:00 - 13:30Working Group 11: E-Mobility AustriaBreakout
07:00 - 16:00Junior Alpbach – Science and technology for young peopleBreakout
07:00 - 13:00Ö1 Children’s University Alpbach – Science and technology for kidsBreakout
07:00 - 13:00Technology Workshop: Trend radar of developments in societyBreakout
08:00 - 13:00Special Event: Positioning Austria in the international knowledge areaBreakout
14:30 - 15:45Creativity. How kids learn – learning like kids do?Plenary
16:15 - 18:00Innovative research locations – regions in competitionPlenary

29.08.2009

07:30 - 08:45Can we trust in science? Integrity in scientific researchPlenary
08:45 - 09:30The future of the universe – perspectives for astrophysics and cosmologyPlenary
10:00 - 11:00I-Brain – the technological evolution of the brain?Plenary
11:00 - 11:15Closing statementPlenary
11:15 - 12:00Snack receptionSocial